产品

Home
产品
iPSC Derived Hepatocytes

Hepatosight®-S | iPSC Derived Hepatocytes

目录编号	内容	卷	加入购物车
H-001	NEXEL Hepatosight®-S, small Hepatosight®-S, Cryopreserved hiPSC-derived Hepatocytes	Out of stock ≥ 5 × 10⁶ Viable cells / Vial	加入购物车
H-002	NEXEL Hepatosight®-S, large Hepatosight®-S, Cryopreserved hiPSC-derived Hepatocytes	≥ 10 × 10⁶ Viable cells / Vial	加入购物车
HMS-001	Hepatosight®-S Media Kit Hepatosight®-S Media (HM-001, 100 ml) Hepatosight®-S Media Supplement (HS-001, 0.7 ml, 100X)	100 ml	加入购物车
HMS-002	Hepatosight®-S Media Kit Hepatosight®-S Media (HM-002, 200 ml) Hepatosight®-S Media Supplement (HS-002, 1.2 ml, 100X)	200 ml	加入购物车
H-001	NEXEL Hepatosight®-S, small Hepatosight®-S, Cryopreserved hiPSC-derived Hepatocytes	Out of stock ≥ 5 × 10⁶ Viable cells / Vial	加入购物车
H-002	NEXEL Hepatosight®-S, large Hepatosight®-S, Cryopreserved hiPSC-derived Hepatocytes	≥ 10 × 10⁶ Viable cells / Vial	加入购物车
HMS-001	Hepatosight®-S Media (HM-001, 70 ml) Hepatosight®-S Media Supplement (HS-001, 0.7 ml)	70 ml	加入购物车
HMS-002	Hepatosight®-S Media (HM-002, 120 ml) Hepatosight®-S Media Supplement (HS-002, 1.2 ml)	120 ml	加入购物车

添加到购物车

该产品已成功添加到购物车。

购物车移动继续购物

关闭

产品说明 | iPSC Derived Hepatocytes

欢迎您了解Next Human induced Pluripotent Stem Cell （iPSC）-derived Hepatocytes。. 肝毒性在药物开发方面属于最基本的问题，是药物消耗的主要原因之一。目前的方法严重依靠人类肝细胞，其缺乏体现再现性或非正常表现性的永生化细胞。其中无论哪一种模型都无法满足想要填补体外研究及缺损状态的 iPSC-derived hepatocytes 衍生的肝细胞的需求。
NEXEL使用最优化独家协议，致力于提供源自人类诱导性多能干细胞（iPS）的优质人类肝细胞。Hepatosight®-S是纯粹的机能活性细胞集合，适合进行肝细胞领域所有种类的试验。本公司的首要任务是支援研究者获得可信赖的产品，并加快各种项目的研究速度。